Or Refractory B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Or Refractory B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma [Phase 1, Phase 2]
MS-553 trial in relapsed/refractory B-cell lymphomas was terminated after Phase 1/2 studies.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma [Phase 4]
Phase 4 clinical trial update for relmacabtagene autoleucel infusion in relapsed or refractory B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Dual Target CAR-T Cells in B-cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for dual-target CAR-T cells in B-cell lymphoma is ongoing, with the sponsor listed and the status currentl…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: CART-19 Cells for R/R B-cell Lymphoma [Phase 2, Phase 3]
Clinical trial update for CART-19 cells targeting Relapsed or Refractory B-cell Lymphoma, in Phase 2 and Phase 3.